. ERK signaling is not activated at early hypertension. a, Western blot analysis for the level of phospho-ERK (pERK) and total ERK in the aortic tissue from the saline-or AngII-infused mice. The ratio of pERK and total-ERK is shown (n=7). N.S.; not significant. b, Western blot analysis for pERK and total ERK in HASMCs treated with AngII (2 M). c,
. -catenin signaling is activated in aortic media after AngII-infusion. a, Left, immunofluorescence staining of aortic tissues from 1 week AngII-infused mice using isotype control antibody. Right, immunofluorescence staining of aortic tissues from AngII-infused mice using antigen specific antibodies: SMA, -catenin, Axin2, CD206, F4/80, BrdU, and CD31. The images immunostained with each corresponding isotype control are shown on the left side. The IgG isotype of anti-F4/80 antibody, anti-BrdU antibody, and anti-CD31 antibody were the same. Scale bar, 50m. b, Immunostaining of aortic tissue from 1 week AngII-infused mice for -catenin (red), Axin2 (green), and DAPI (blue). The magnified view shows the co-localization of -catenin and DAPI in aortic media indicating the nuclear translocation of -catenin. Scale bar, 20m. c, Aortic tissues from 1 week salineor AngII-infused mice were immunostained for CD31 (green) and -catenin (red). Scale bar, 50 m. Figure 3 . High blood pressure partly contributes to activation of -catenin signaling. a, Increased systolic blood pressure after 1week AngII-infusion was lowered by hydralazine treatment. **p<0.01 versus AngII-infused mice treated with PBS (AngII). b, The number of double positive (BrdU(+)/SMA(+)) cells per section from 1 week saline-infused mice (Saline), 1 week AngII-infused mice treated with PBS (AngII), or with hydralazine (AngII+hydralazine). *p<0.05 versus 1 week AngII-infused mice treated with PBS (n=6-7). c, Western blot analysis for non-phosphorylated active -catenin (ABC) in the aortic tissues from 1 week saline-infused mice (Saline), 1 week AngII-infused mice treated with PBS (AngII), or 1 week AngII-infused mice treated with hydralazine (AngII+hydralazine). Densitometric analysis for the amount of ABC in the aortic tissue from each group is shown. Activation of -catenin signaling was quantified by measuring the relative level of ABC over actin. The values are shown as fold induction over saline-infused mice. **p<0.01 versus saline-infused mice, #p<0.05 versus AngII-infused mice (n=7). d, Western blot analysis. HASMCs were treated with AngII (2 M) and the amount of ABC was analyzed. e, Cell surface area of HASMCs was measured using ImageJ after AngII (2 M) or Wnt3A (80 ng/ml) treatment. The values are shown as fold induction over non-treated HASMCs (Con). **p <0.01 versus non-treated HASMCs (n=3). f, Systolic blood pressure after 1week AngII-infusion. PKF or C1-INH treatment did not affect blood pressure. C1qKO or C3KO mice showed blood pressure levels similar to wild type mice.
Supplementary
Statistical significance was determined using the one-way ANOVA with Turkey's post hoc test for a-c, e, f. Results are represented as mean ± SD. 

